217 results
Page 6 of 11
DEFA14A
EX-10.1
r5kj97dhqar
2 Apr 12
Additional proxy soliciting materials
12:00am
8-K
EX-10.1
flad4j
2 Apr 12
GlaxoSmithKline to increase its ownership in Theravance
12:00am
8-K
EX-99
lkhkvv4t u888c3
9 Jan 12
Other Events
12:00am
8-K
EX-99.1
setvwaol7zyjk
12 Jan 11
Regulation FD Disclosure
12:00am
8-K
EX-10.1
rpr3p1
29 Nov 10
GlaxoSmithKline to Increase Its Shareholding in Theravance
12:00am
8-K
EX-99.2
ixgm06le69us9
21 Oct 10
Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development
12:00am
8-K
EX-99.1
j8sh7w
21 Oct 10
Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development
12:00am
424B5
k7zbckvg1f
19 Mar 10
Prospectus supplement for primary offering
12:00am